Mutant p53 Associates with Human Equilibrative Nucleoside 1 Upregulation and Better Response to Adjuvant Gemcitabine in Intrahepatic Cholangiocarcinoma Patients. This evidence concerns the gene TP53 and intrahepatic cholangiocarcinoma.